SCHEMBL5547564

SCHEMBL5547564

CC(C)(C)[Si](C)(C)OC1CNN(OC(=O)Nc2ccc(Cl)cc2)C1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.38
NPC1 O15118 3/20 0.38
MAPT P10636 4/20 0.37
XBP1 P17861 1/20 0.37
MAPK1 P28482 1/20 0.37
ALDH1A1 P00352 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
RORC P51449 1/20 0.35
CYP2C19 P33261 4/20 0.34
CYP1A2 P05177 3/20 0.34
CYP2D6 P10635 3/20 0.34
CYP3A4 P08684 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
GAA P10253 1/20 0.34
GRM5 P41594 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
POLB P06746 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4450749 0.84 KMT2A (0.38) RAB9ANPC1MAPTMAPK1SMN1; SMN2
SCHEMBL4447149 0.73 NPC1 (0.39) RAB9ANPC1MAPTMAPK1ALDH1A1
SCHEMBL5549338 0.72
SCHEMBL17728963 0.72 L3MBTL1 (0.40) RAB9ANPC1MEN1KMT2AL3MBTL1
SCHEMBL5549316 0.69 POLB (0.35) RAB9ANPC1MAPTMAPK1SMN1; SMN2
SCHEMBL17729044 0.69 PTPN2 (0.49) RAB9ANPC1MAPTALDH1A1CYP3A4
SCHEMBL13787490 0.67 USP2 (0.33) SMN1; SMN2
SCHEMBL4444868 0.66 F10 (0.54)
SCHEMBL4450044 0.65 PPM1D (0.34)
SCHEMBL22903476 0.64 KCNH2 (0.34) MAPK1ALDH1A1CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1608645-B1 PYRAZOLIDINE-1,2-DICARBOXYLDIPHENYLAMIDE DERIVATIVES AS COAGULATION FACTOR XA INHIBITORS FOR THE TREATMENT OF THROMBOSES MERCK PATENT GMBH (DE) 2007-05-02 EP disclosed